, the details of ligandinduced signal transduction are not well understood owing to missing dynamical information. In principle, such information can be provided by NMR 4 , but so far only limited data of functional relevance on few side-chain sites of eukaryotic GPCRs have been obtained [5][6][7][8][9] . Here we show that receptor motions can be followed at virtually any backbone site in a thermostabilized mutant of the turkey β 1 -adrenergic receptor (β 1 AR) [10][11][12] . Labelling with [ 15 N]valine in a eukaryotic expression system provides over twenty resolved resonances that report on structure and dynamics in six ligand complexes and the apo form. The response to the various ligands is heterogeneous in the vicinity of the binding pocket, but gets transformed into a homogeneous readout at the intracellular side of helix 5 (TM5), which correlates linearly with ligand efficacy for the G protein pathway. The effect of several pertinent, thermostabilizing point mutations was assessed by reverting them to the native sequence. Whereas the response to ligands remains largely unchanged, binding of the G protein mimetic nanobody NB80 and G protein activation are only observed when two conserved tyrosines (Y227 and Y343) are restored. Binding of NB80 leads to very strong spectral changes throughout the receptor, including the extracellular ligand entrance pocket. This indicates that even the fully thermostabilized receptor undergoes activating motions in TM5, but that the fully active state is only reached in presence of Y227 and Y343 by stabilization with a G protein-like partner. The combined analysis of chemical shift changes from the point mutations and ligand responses identifies crucial connections in the allosteric activation pathway, and presents a general experimental method to delineate signal transmission networks at high resolution in GPCRs.
N]valine in a eukaryotic expression system provides over twenty resolved resonances that report on structure and dynamics in six ligand complexes and the apo form. The response to the various ligands is heterogeneous in the vicinity of the binding pocket, but gets transformed into a homogeneous readout at the intracellular side of helix 5 (TM5), which correlates linearly with ligand efficacy for the G protein pathway. The effect of several pertinent, thermostabilizing point mutations was assessed by reverting them to the native sequence. Whereas the response to ligands remains largely unchanged, binding of the G protein mimetic nanobody NB80 and G protein activation are only observed when two conserved tyrosines (Y227 and Y343) are restored. Binding of NB80 leads to very strong spectral changes throughout the receptor, including the extracellular ligand entrance pocket. This indicates that even the fully thermostabilized receptor undergoes activating motions in TM5, but that the fully active state is only reached in presence of Y227 and Y343 by stabilization with a G protein-like partner. The combined analysis of chemical shift changes from the point mutations and ligand responses identifies crucial connections in the allosteric activation pathway, and presents a general experimental method to delineate signal transmission networks at high resolution in GPCRs.
A thermostabilized, detergent-resistant mutant of β 1 AR [10] [11] [12] (TS-β 1 AR; see Methods) was selectively labelled with [ 15 N]valine and produced in insect cells without further chemical modifications. Its 28 valine residues are homogeneously distributed across the receptor (Extended Data Fig. 1 ) at locations suitable to sense ligand binding and receptor activation. Although resonances of main chain atoms are considerably more difficult to observe than those of mobile side chains of surface residues, they are expected to be better reporters of functional, long-range backbone motions. We succeeded to obtain well-resolved TROSY (transverse relaxation-optimized spectroscopy) spectra of the valine 1 H-15 N backbone resonances of detergentsolubilized TS-β 1 AR in its apo form and in complexes with six ligands (Extended Data Fig. 1 ) ranging in their efficacy from antagonists to agonists (Extended Data Table 1 ). Despite the absence of deuteration and very short T 2 relaxation times (~4 ms for 1 H N ), 26 valine resonances could be observed with sufficient sensitivity and resolution.
Distinct and reversible chemical shift changes were detected for many valines after ligand exchange. 16 valines were assigned unambiguously and 5 tentatively using spectra from 18 point mutants, as well as further spectral and structural information (Extended Data Table 2 ).
Many valine residues in the vicinity of the ligand binding pocket could be assigned, showing chemical shift changes that report on the ligand functional groups (Fig. 1) . Remarkably, residue V172(4.56) (the number in parenthesis corresponds to the Ballesteros-Weinstein numbering system 13 ), which is located close to the ligand aromatic head group, exhibits an unusual Fig. 1c ). This anomaly seems caused by a distorted backbone geometry, which is presumably conserved among adrenergic receptors and results from a missing hydrogen bond to the proline at position 176(4.60) (Extended Data Fig. 2) . Instead, the carbonyl of V172(4.56) participates in a water-mediated hydrogen bond network, which connects the ligand binding site, TM3, TM4, TM5, and TM6 12, 14 . Seemingly as a result of these interactions, the V172(4.56) 1 
H-

15
N resonances cluster according to the substitution patterns of the ligand head group (Fig. 1c) : one cluster is observed for the partial agonists/antagonists cyanopindolol, alprenolol and carvedilol, which have larger head groups with ortho-and/or meta-substitutions; a second cluster is observed for the agonists isoprenaline and dobutamine, which bear a meta-and para-substituted catechol ring. We attribute the distinct chemical shifts for isoprenaline or dobutamine to the loss of a coordinated water caused by specific hydrogen bond interactions between their catechol moieties and the side chain of S215(5.461) (Extended Data Fig. 2d) .
Remarkably, the resonance positions of V172(4.56) in complex with the antagonist atenolol strongly differ from the already described complexes and the apo form: considerable 1 H N (>0.4 p.p.m.) and 15 N (>4 p.p.m.) upfield shifts indicate, respectively, a further weakening of the main chain hydrogen bond V172(4.56)H N ···I168(4.52)O and a stronger kink of the backbone. This rearrangement seems caused by the insertion of the para-acetamide group of the ligand head between residues S215(5.461) and V172(4.56) (Extended Data Fig. 2d ). This will lead to a substantial disruption of the TM3-TM4-TM5 interface, thereby precluding receptor activation, in agreement with atenolol's inverse agonist pharmacology. Thus, the amide chemical shifts of V172(4.56) constitute a very sensitive readout for the state of this water-mediated, inter-helical activation switch.
The 1 H-15 N chemical shifts of further residues in the vicinity of the binding pocket report on additional characteristics of the ligands. V314(6.59) and V202(ECL2) are located at the extracellular surface of the receptor in a "vestibule" next to the entry/exit pathway of the orthosteric binding site 15, 16 . The resonances of these residues are either severely broadened or undetectable in the absence of ligands, whereas they are observable in the presence of ligands ( Fig. 1d and Extended Data Fig. 3) . A line shape analysis for V314(6.59) (Extended Data Fig. 4) 
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indicates that this extracellular part of the receptor undergoes microto millisecond motions in the apo form, which are quenched by ligand binding. This is consistent with results on β 2 AR, which suggest that high-affinity ligands stabilize the conformation of ECL2 and ECL3 5 . The ligand-induced shifts of the V314 resonance correlate strongly (r 2 = 0.95) with the reported ligand affinity 17 (Fig. 1d) . Interestingly, the resonances of V314(6.59) in the apo form and in high-affinity ligand complexes are very close. This may indicate that the highaffinity ligand complexes mimic the average apo conformation. Finally, the 1 H-15 N chemical shifts of V125(3.36) at the bottom of the binding site and of V103(2.65) close to the ligand tail reveal additional trends ( Fig. 1e) : the chemical shifts of V125(3.36) correlate with the depth of ligand insertion towards the central part of TM3 (r 2 = 0.81), whereas those of V103 correlate with the volume of the ligand tail (r 2 = 0.90). Compared to inactive β 2 AR, complexes of activated β 2 AR with either G protein 2 or the G protein-mimicking nanobody NB80 9, 18 show large movements at the intracellular sides of TM5, TM6 and their intervening loop ICL3, which form the binding site for the G protein. These conformational changes are expected to be conserved throughout the GPCR family 19 . Four valine residues could be assigned in this region of TS-β 1 AR: V226(5.57), V230(5.61), V280(6.25) , and V298(6.43) (Fig. 2) . In contrast to the chemical shift changes in the vicinity of the ligand binding pocket, which depend strongly on the ligand chemistry, the shifts of the TM5 residues observed in this region report on ligand efficacy. This effect is most prominent for residue V226(5.57), for which the 1 H-15 N resonances fall on one line from antagonists to agonists (Fig. 2a) . The chemical shifts for the different ligands correlate very strongly (r 2 = 0.89) with their reported 17 efficacies for Gs signalling (Extended Data Table 1 ). This highly linear effect suggests that the receptor filters the diverse input signals from the various ligands to a unified and precise structural response on TM5, which can be read out by the chemical shifts of V226(5.57). Interestingly, the V226(5.57) atenolol peak is situated at a position corresponding to lower efficacy than for the apo receptor. This gives direct structural evidence of atenolol's inverse agonist action, which reduces the activation relative to the basal level of the apo receptor.
Current high-resolution structures of β 1 AR do not show significant changes between antagonist-and agonist-bound forms (Fig. 2b) G s pathway (Fig. 2c) . As this residue is located one helical turn further towards the cytoplasm, the detected conformational change is not just local, but spans a certain length in TM5.
Compared to V226(5.57) and V230(5.61) in TM5, the chemical shift response to ligands is much less pronounced for V298(6.43) and in particular V280(6.25) at the intracellular side of TM6 (Fig. 2c) . This suggests that agonist binding to the TS-β 1 AR does not induce the large conformational change in TM6 observed in the activated β 2 AR-G protein 2 or β 2 AR-NB80 18 complexes. However, G protein activation upon agonist binding has been reported for other less thermostabilized β 1 AR constructs 17 , indicating that they can still be activated, albeit at low levels. Thus we reverted the mutations most likely to interfere with the activation mechanism in TS-β 1 AR, that is, I129(3.40)V in the connector switch 15 , Y227(5.58)A in TM5 21, 22 , and Y343(7.53)L in the NPxxY motif of TM7 14, 22 to the native residues. These reverse mutants were then tested for G protein activation and the NMR response in TM6. A summary of the results is given in Extended Data Table 3 . The original TS-β 1 AR, the single mutants TS-β 1 AR(V129I), TS-β 1 AR(A227Y), and TS-β 1 AR(L343Y) as well as the double mutant TS-β 1 AR(V129I/A227Y) showed no detectable G protein activation upon isoprenaline binding (Extended Data Fig. 5 ). However, G protein activation was detectable for the least thermostable TS-β 1 AR(A227Y/L343Y) double mutant (T m reduced by 11 °C relative to TS-β 1 AR), which recovers the conserved tyrosines in TM5 and TM7 that are known to stabilize the active state of rhodopsin 22 . None of the reverse mutants showed major changes in the NMR spectra of various ligand complexes compared to the original TS-β 1 AR (Extended Data Fig. 6 ). In particular, residues V298(6.43) and V280(6.25) at the intracellular side of TM6 did not show an increased response to agonists. This is in agreement with recent DEER (double electron-electron resonance) and 19 F-NMR data showing that agonists alone do not fully stabilize the active state of TM6 in β 2 AR 9 . Interestingly, the V129(3.40)I and the V129(3.40)I/A227(5.58)Y mutations shifted the 1 H-15 N resonances of V226(5.57) towards a more active (that is, bent) state of TM5 in both the atenolol-and isoprenaline-bound forms (Extended Data Fig. 6b ), thereby given direct experimental evidence for an allosteric activation pathway spanning about 13 Å from I129(3.40) on TM3 to V226(5.57) on TM5.
With the exception of rhodopsin 23 , the stabilization of fully active GPCR conformations seems to require binding of an agonist and an intracellular partner 8, 9 . Indeed, when both the agonist isoprenaline and the G protein-mimicking nanobody NB80
18 were added to TS-β 1 AR(A227Y/L343Y), very large chemical shift responses for many valine residues in TM3-TM6 were observed, whereas no change was observed for several valines in TM1, 2, and 7 (Extended Data Fig. 7 ). This very strong response extends even to the extracellular residue V314(6.59), providing evidence of a long-distance connection from the G protein binding site to the ligand entry site. The strong chemical shift changes are reverted when the partial agonist/antagonist cyanopindolol is added to the isoprenaline-TS-β 1 AR(A227Y/L343Y)-NB80 complex. The spectrum then becomes identical to that of the 'pure' cyanopindolol-TS-β 1 AR(A227Y/L343Y) complex (Extended Data Fig. 7a ), indicating that cyanopindolol replaces isoprenaline and causes the release of NB80. In agreement with the G protein activation data, the isoprenaline-bound original TS-β 1 AR and the mutants TS-β 1 AR(A227Y) and TS-β 1 AR(L343Y) did not show binding of NB80 in the NMR spectra. Moreover, supplementing NB80 to the ultrastable TS-β 1 AR did not change its affinity for isoprenaline (Extended Data Fig. 7b ), whereas it caused a hundred-fold affinity increase in the case of TS-β 1 AR(A227Y/L343Y) and the truncated native turkey β 1 AR receptor (tβtrunc) 17 . This increase is identical to data for β 2 AR 18 and shows the energetic coupling between the NB80 and agonist binding also for β 1 AR.
In combination, these data prove that agonist binding, even in the absence of a G protein mimic, induces initial changes in the conformational equilibrium of TM5 towards the conformation observed in the G protein complex of β 2 AR. Remarkably, these rearrangements occur in all thermostabilized forms of β 1 AR. However, a full shift of the equilibrium towards such an active conformation, including allosteric Letter reSeArCH changes at the extracellular side, occurs only when G protein or its mimetic NB80 is bound. This process requires the presence of both Y227(5.58) and Y343(7.53), which significantly reduce the thermal stability. Different active conformations may be reached for non-G protein effectors such as β-arrestin.
The possibility to detect NMR signals at many receptor sites in response to ligand binding and point mutations provides an experimental method to trace allosteric signalling paths. Figure 3 shows examples of these pathways, derived from the response to the ligands atenolol and isoprenaline and the single point mutations V129(3.40)I, A227(5.58)Y, and L343(7.53)Y. Choosing a cutoff of 0.05 p.p.m. for the resulting combined 1 H, 15 N chemical shift change (Fig. 3a , red line), longrange (>10 Å) connections become evident throughout the receptor (Fig. 3b, c) . Whereas detected ligand signals radiate broadly to almost all helices, the point mutants give evidence of smaller interaction networks connecting TM3 to TM4/5, TM5 to TM3/4/6, as well as TM7 to TM2/3 (Fig. 3b, c) . Interestingly, the TM2/TM7 network seems to be only weakly connected to the TM3-TM6 network. Together, these data provide experimental evidence at high resolution of an extensive signal transduction network that connects the ligand binding site to the intracellular sides of TM5, TM6, and TM7. Such a network of loosely coupled allosteric connections has been postulated previously for β 2 AR on the basis of molecular dynamics simulations 24 . In summary, we have shown that highly resolved solution NMR backbone spectra can be obtained for a eukaryotic GPCR. The NMR observations delineate the allosteric signalling pathways and comprehensively connect many previous experimental and theoretical observations, which may ultimately allow to understand the dynamic mechanisms of GPCRs at the atomic level.
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MethODS β 1 AR constructs. The TS-β 1 AR mutant was derived from the turkey β 1 AR44-m23 mutant used in crystallographic studies 25 by adding three additional thermostabilizing mutations (I129V, D322K, and Y343L) and a neutral mutation (D200E) from the ultra-stable β 1 AR-JM3 mutant 11 . As compared to the wild type, TS-β 1 AR contains truncations at the amino and carboxy termini and intracellular loop (ICL3), a total of nine thermostabilizing point mutations, three further point mutations as well as a C-terminal hexahistidine tag (Extended Data Fig. 1 Additional valine-to-alanine or isoleucine point mutations were introduced into TS-β 1 AR for NMR assignment purposes. All constructs were made using the QuikChange site-directed mutagenesis method (Agilent). Baculovirus for insect cell expression was generated using the Bac-to-Bac system (Invitrogen). β 1 AR expression and purification. All β 1 AR constructs were expressed in baculovirus-infected insect cells as described 26 . Selective labelling by [ 15 N]valine was achieved by growing cells on unlabelled serum-free insect cell medium (InsectXpress, Lonza) and then exchanging into custom-made serum-free medium (SF4, BioConcept) devoid of valine and yeast extract, to which 100 mg l −1 [
15 N] valine were supplemented. Virus was added immediately after the medium exchange. The culture was harvested at 48 or 72 h post infection.
After cell lysis, the membrane fraction was separated from the lysate via ultracentrifugation and subsequently solubilized with 2% n-decyl-β-d-maltopyranoside (DM, Anatrace). The solubilized membrane fraction was then purified by nickel ion affinity chromatography followed by alprenolol ligand affinity chromatography. The active receptor was eluted with buffer (20 mM Tris, 350 mM NaCl, 0.1% DM, pH 7.5) containing either atenolol (1 mM) or alprenolol (0.1 mM). Final yields of detergent-solubilized receptor were 1.5 mg l −1 of cell culture. The molecular weight of the receptor-detergent complex was estimated as ~100 kDa by static light scattering. Thermal shift assays of mutant receptors. Detergent-solubilized, purified apo TS-β 1 AR and reverse-mutation receptors for thermal stability assays were obtained from their atenolol-bound form by washing with buffer devoid of ligand on a HiTrap SP HP (GE Healthcare) column. Their thermal stability was determined by the microscale fluorescent stability assay for binding of the thiolspecific fluorochrome N-[4-(7-diethylamino-4-methyl-3-coumarinyl)phenyl] maleimide (CPM) 27 in a Rotor-Gene Q (QIAGEN) real-time PCR cycler using 1 μg of receptor in 20 mM Tris, 350 mM NaCl, 0.1% DM, pH 7.5 and a heating rate of 2 K min −1 . NMR experiments. NMR samples were prepared in Shigemi tubes as 250 μl volumes of typically 100 μM receptor, 1 mM ligand (except for apo form), 20 mM TRIS, 100 mM NaCl, 0.1% DM, 5% D 2 O, pH 7.5. For isoprenaline or dobutamine, 2 mM of sodium l-ascorbate were supplemented as anti-oxidant. All solution NMR measurements were carried out at 304 K on a 800 MHz or a 900 MHz Bruker Avance III spectrometer equipped with a cryogenic probe. 2D 1 H, 15 N TROSY spectra were recorded with total acquisition periods of 16 ms ( 15 N) and 43 ms ( 1 H) with typical total experimental times of 24-48 h. As compared to a standard TROSY pulse sequence, the 1 H-15 N INEPT delays were set to 3 ms to reduce magnetization losses from relaxation. Assignment procedure. To obtain sequence-specific assignment information, we initially attempted to detect HNCO and HNCA correlations on samples additionally labelled with 13 C at specific backbone sites 28 . However, due to low sensitivity, only very few correlations were observable. Therefore, assignments were obtained from a combination of information from TROSY spectra recorded on 18 TS-β 1 AR valine point mutants with different ligands, four HN(CO) correlations and five distinct structure-based chemical shift predictions (Extended Data Table 2 ). Ligand exchange experiments. Receptor complexes with different ligands were generated by sequential exchange according to increasing ligand affinity, that is, in the sequence atenolol-isoprenaline-dobutamine-alprenolol or alprenololcarvedilol-cyanopindolol. For exchange, the sample was washed three times with buffer devoid of ligand at tenfold dilution in Amicon Ultra 50 kDa cutoff concentrators. Subsequently, the sample was washed again twice with buffer containing 100 μM new ligand, separated by a period of 1 h incubation. Final concentrations of the ligands were adjusted to 1 mM. Apo receptor was generated from the atenolol complex by six washing steps of tenfold dilution in ligand-free buffer using a 1 h incubation period for the last three steps. NMR NB80 binding experiment. Binding of NB80 to β 1 AR mutants was assessed using TROSY and 1D proton NMR spectra. These spectra were recorded on the β 1 AR mutants (TS-β 1 AR: 132 μM, TS-β 1 AR(A227Y): 120 μM, TS-β 1 AR(L343Y): 110 μM, and TS-β 1 AR(A227Y/L343Y): 120 μM) in the presence of saturating amounts (1 mM) of the agonist isoprenaline before and immediately after addition of an equimolar (relative to the receptor) amount of NB80. For TS-β 1 AR(A227Y/ L343Y) additional spectra were recorded after a further addition of the partial agonist cyanopindolol (1 mM) to the already present isoprenaline and NB80. Scintillation proximity assay with 3 H-dihydroalprenolol. For pharmacological binding assays membranes were prepared from SF9 insect cells as described previously 26 . The total protein content of the membranes was estimated by A280 measurements using an average extinction coefficient of 1.0 per mg ml −1 . All assays were carried out in 96-well plates at 200 μg ml −1 total protein in membranes and 2 mg ml −1 WGA-YSi beads (Perkin-Elmer) in a 100 μl total volume per well. Samples were equilibrated at room temperature for at least 16 h. K D values for the radioactive ligand [ H-DHA from 0.032 to 100 nM. Non-specific binding was determined in presence of 1 μM S-propanolol to block the ligand binding site. Competition assays were performed in the presence of 20 nM 3 H-DHA (hot ligand) and increasing concentrations of the competitor (cold ligand). Dilutions of alprenolol, atenolol, cyanopindolol, dobutamine and isoprenaline were made with phosphate buffered saline (PBS, Biochrom, Germany). Due to the limited solubility of carvedilol in water, stock dilutions of carvedilol were prepared in DMSO. The final concentration of DMSO in the samples was 5%. To test the effect of NB80 binding on the affinities (IC 50 ) of isoprenaline for various receptor mutants, the competition assays were also carried out in the presence of saturating concentrations of NB80 (10 μM). IC 50 values were determined by fitting the measured radioactive counts per minute CPM(X) at a specific concentration X of the competitor to the equation where A is the concentration of the radioactive ligand and K D is its affinity for the receptor determined in the direct binding experiment. G protein activation assay. G protein activation was measured on purified β 1 AR mutants reconstituted with MSP1E3D1 29 into POPC/POPG nanodiscs. MSP1E3D1 was expressed and purified as described 29 and cleaved with TEV protease. 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC, Avanti Polar Lipids) and 1-palmitoyl-2-oleoyl-sn-glycerol-3-phospho-(1′-rac-glycerol) sodium salt (POPG, Avanti Polar Lipids) were solubilized at a ratio of 1:1.5 (w/w) POPG/POPC in ND buffer (20 mM HEPES pH 8, 100 mM NaCl, 1 mM EDTA) with 50 mM sodium cholate (Sigma-Aldrich) at 4 °C. 133.3 μM MSP1E3D1 was incubated with 8 mM solubilized POPC/POPG and 10 μM purified β 1 AR in ND buffer with a final concentration of 24 mM sodium cholate for 1 h at 4 °C. Nanodiscs containing the receptor were separated from empty nanodiscs using a cobalt-chelating resin. The heterotrimeric G protein was prepared by incubating 10 μM recombinant Gα i1 and 10 μM native Gβγ t in activation buffer (25 mM HEPES pH 7.5, 150 mM NaCl, 2 mM MgCl 2 , 1 mM DTT) for 30 min at 4 °C.
G protein activation was detected by the change in tryptophan fluorescence caused by the exchange of GDP for GTPγS, associated conformational changes in the Gα subunit and its dissociation from the Gβγ subunit of the hetero trimeric G protein 30 . All measurements were carried out on a Varian Cary Eclipse fluorescence spectrophotometer (λ ex = 295 nm, λ em = 340 nm, 1.5 nm excitation slit, 20 nm emission slit, 2 s averaging time, 15 s cycle time) using final sample volumes of 1 ml in 10 × 4 mm cuvettes (Hellma, CH) and magnetic stirrers at 20 °C. Prior to activation, the fluorescence intensity baseline was recorded with 100 nM heterotrimeric G protein for approximately 500 s. The activation was started by adding 6 nM β 1 AR and 10 μM GTPγS, and the fluorescence intensity was monitored for a further 1 h. For experiments in the presence of an agonist, the concentrated receptor stock solution (1.5 μM) was pre-incubated for 30 min at 4 °C with 40 μM isoprenaline, and the buffer during the measurements contained 2 μM of isoprenaline to maintain the saturation conditions for the receptor. V165(4.49) , which has normal, helical phi and psi angles. d, Partial views of the crystal structures of the carvedilol complex (PDB code 4AMJ), the isoprenaline complex (PDB code 2Y03) and a docking model of the atenolol complex based on the cyanopindolol complex crystal structure (PDB code 4BVN). In the carvedilol complex, one water molecule (w2) forms a hydrogen bond network between the carbonyl oxygen of V172(4.56) and the side chains of S211(5.43) and S215(5.461). In the isoprenaline complex, the side chains of S211(5.43) and S215(5.461) are rotated and form hydrogen bonds to the catechol hydroxyl groups of isoprenaline. In this structure, no water molecule is observed at the equivalent position of w2. In the atenolol complex, the para-substituted acetamide of the ligand head ring (dashed circle) inserts between S211(5.43) and S215(5.461) and disturbs the interface between TM3 and TM5 near V172(4.56) (solid circle). TM5   TM7   TM1   H8   TM6   TM1  TM2  TM3   TM4   906   2  89  90  94  95  102  103  122  125  129  134  160  165  172  202  226  230  280  298 /L343Y ). a, Sequential addition of isoprenaline (1 mM, blue), NB80 (120 μM, red), and cyanopindolol (1 mM, green) to TS-β 1 AR(A227Y/L343Y) (120 μM) followed by 1 H-15 N TROSY spectra. Addition of an equimolar amount of NB80 changes the spectrum drastically. Except for few resonances (62, 89, 102, 103, 172, 280 and 326) , the assignments are not transferable from the isoprenaline complex. The addition of cyanopindolol to this mixture apparently replaces isoprenaline in the receptor and drives the spectrum to the purely cyanopindololbound form. These results indicate that TS-β 1 AR(A227Y/L343Y) can be activated, but that the fully active state requires stabilization with a G protein-like partner at the intracellular site. b, Changes in isoprenaline affinity of β 1 AR induced by NB80 binding. The isoprenaline affinity was assayed for TS-β 1 AR (orange), TS-β 1 AR(A227Y/L343Y) (green), and the truncated native turkey β 1 AR receptor (tβtrunc, blue) 17 by radio-ligand competition using 3 H-dihydroalprenolol in the presence of saturating amounts of NB80 (10 μM, squares) or its absence (circles). For TS-β 1 AR(A227Y/L343Y) and tβtrunc the apparent affinity increases by two log units in the presence of NB80, whereas no change occurs for TS-β 1 AR. Data points are shown as mean and standard deviation of three independent experiments for each condition. c, Combined 1 H and 15 N chemical shift changes (Δδ = (Δδ 1H 2 /2 + Δδ 15N 2 /50) 1/2 ) between the isoprenaline-TS-β 1 AR(A227Y/L343Y) and the NB80-isoprenaline-TS-β 1 AR(A227Y/L343Y) complexes as a function of residue number. Except for the few assigned peaks in the NB80-isoprenaline-TS-β 1 AR(A227Y/ L343Y) complex, chemical shift deviations are calculated as the minimal difference from the isoprenaline peak position to the nearest peak position in the isoprenaline-NB80 complex. Note that these minimal chemical shift deviations present a lower boundary for the deviations that could be obtained from a full assignment of the isoprenaline-NB80 complex. 
